(Q40469912)

20 September 2017

1 reference

title

Geographical and temporal patterns of incidence and mortality from prostate cancer. (English)

1 reference

20 September 2017

1

1 reference

20 September 2017

2

1 reference

20 September 2017

Napalkov P

3

1 reference

PubMed ID

7653020

20 September 2017

language of work or name

English

0 references

publication date

1 September 1995

1 reference

20 September 2017

1 reference

20 September 2017

46

1 reference

20 September 2017

47-55

1 reference

20 September 2017

3 Suppl A

1 reference

Cancer in the European community and its member states

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980250-7

7 January 2021

Cancer statistics, 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980250-7

7 January 2021

Prospects for an ageing population

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980250-7

7 January 2021

Estimates of the worldwide incidence of eighteen major cancers in 1985.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980250-7

7 January 2021

Risk factors for prostate and testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980250-7

7 January 2021

Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980250-7

7 January 2021

Incidental carcinoma of the prostate. How much sampling is adequate?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980250-7

7 January 2021

Estimates of the worldwide frequency of sixteen major cancers in 1980

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980250-7

7 January 2021

Have transurethral resections contributed to the increasing incidence of prostatic cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980250-7

7 January 2021

Public health perspective: the health policy implications of screening for prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980250-7

7 January 2021

The use of prostate specific antigen for prostate cancer screening: a managed care perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980250-7

7 January 2021

Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980250-7

7 January 2021

Results of conservative management of clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980250-7

7 January 2021

Changes in prostate cancer incidence and treatment in USA

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980250-7

7 January 2021

Rising trends of oral cancer mortality among males worldwide: the return of an old public health problem

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980250-7

7 January 2021

Recent trends in mortality from prostate cancer in male populations of Australia and England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980250-7

7 January 2021

Screening for prostate cancer--necessity or nonsense?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980250-7

7 January 2021

10.1016/S0090-4295(99)80250-7

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7653020